Best TWAS P=3.85e-10 · Best GWAS P=5.75e-09 conditioned to 0.747
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Visceral Omentum | IRF5 | 0.16 | 0.08 | lasso | 4 | 0.08 | 8.2e-05 | 5.4 | 5.7 | 1.2e-08 | -0.87 | 0.01 | 0.98 | FALSE |
2 | GTEx | Colon Transverse | IRF5 | 0.21 | 0.22 | lasso | 4 | 0.22 | 8.0e-11 | 5.4 | 5.5 | 3.5e-08 | -0.86 | 0.01 | 0.99 | FALSE |
3 | GTEx | Esophagus Mucosa | IRF5 | 0.13 | 0.14 | lasso | 4 | 0.13 | 4.6e-09 | 5.4 | 5.4 | 8.3e-08 | -0.84 | 0.01 | 0.99 | FALSE |
4 | GTEx | Esophagus Muscularis | IRF5 | 0.21 | 0.12 | lasso | 5 | 0.11 | 3.9e-07 | 5.4 | 5.6 | 2.1e-08 | -0.87 | 0.01 | 0.99 | FALSE |
5 | GTEx | Nerve Tibial | IRF5 | 0.13 | 0.09 | enet | 10 | 0.07 | 1.2e-05 | 5.4 | 5.7 | 1.4e-08 | -0.90 | 0.01 | 0.99 | FALSE |
6 | GTEx | Skin Sun Exposed Lower leg | IRF5 | 0.10 | 0.14 | lasso | 2 | 0.12 | 1.9e-10 | 5.4 | 5.6 | 1.8e-08 | -0.87 | 0.00 | 0.99 | FALSE |
7 | GTEx | Whole Blood | IRF5 | 0.17 | 0.06 | lasso | 4 | 0.09 | 1.2e-08 | -4.8 | 5.6 | 1.9e-08 | -0.90 | 0.02 | 0.98 | FALSE |
8 | METSIM | Adipose | IRF5 | 0.05 | 0.04 | lasso | 7 | 0.04 | 2.2e-06 | 5.4 | 5.5 | 4.7e-08 | -0.82 | 0.02 | 0.98 | FALSE |
9 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | IRF5 | 0.09 | 0.06 | blup | 30 | 0.08 | 1.8e-07 | -4.8 | 5.2 | 1.8e-07 | -0.78 | 0.01 | 0.98 | FALSE |
10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | IRF5 | 0.10 | 0.09 | lasso | 4 | 0.08 | 1.6e-16 | 5.4 | 5.4 | 7.7e-08 | -0.84 | 0.01 | 0.99 | FALSE |
11 | The Cancer Genome Atlas | Colon Adenocarcinoma | IRF5 | 0.29 | 0.26 | enet | 6 | 0.29 | 3.1e-17 | -5.8 | 6.0 | 2.0e-09 | -0.96 | 0.00 | 1.00 | FALSE |
12 | The Cancer Genome Atlas | Glioblastoma Multiforme | IRF5 | 0.18 | 0.02 | enet | 8 | 0.04 | 2.4e-02 | -4.2 | 6.0 | 2.2e-09 | -0.67 | 0.01 | 0.63 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | IRF5 | 0.11 | 0.05 | blup | 30 | 0.07 | 2.2e-08 | 5.4 | 5.3 | 1.2e-07 | -0.84 | 0.00 | 1.00 | FALSE |
14 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | IRF5 | 0.09 | 0.04 | lasso | 4 | 0.06 | 2.3e-04 | 5.4 | 5.5 | 2.9e-08 | -0.91 | 0.00 | 0.99 | FALSE |
15 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | IRF5 | 0.17 | 0.09 | enet | 6 | 0.15 | 1.8e-07 | -3.9 | 5.6 | 2.4e-08 | -0.84 | 0.01 | 0.99 | FALSE |
16 | The Cancer Genome Atlas | Lung Adenocarcinoma | IRF5 | 0.18 | 0.11 | enet | 9 | 0.14 | 1.6e-15 | 5.4 | 5.5 | 5.0e-08 | -0.86 | 0.00 | 1.00 | FALSE |
17 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | IRF5 | 0.14 | 0.15 | enet | 6 | 0.14 | 7.0e-10 | -5.8 | 5.3 | 9.3e-08 | -0.94 | 0.00 | 1.00 | FALSE |
18 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | IRF5 | 0.09 | 0.10 | lasso | 3 | 0.08 | 4.6e-04 | -5.8 | 5.8 | 5.6e-09 | -1.00 | 0.00 | 0.96 | FALSE |
19 | The Cancer Genome Atlas | Prostate Adenocarcinoma | IRF5 | 0.23 | 0.26 | lasso | 3 | 0.26 | 3.6e-27 | -5.8 | 5.8 | 5.7e-09 | -0.97 | 0.00 | 1.00 | FALSE |
20 | The Cancer Genome Atlas | Rectum Adenocarcinoma | IRF5 | 0.41 | 0.13 | blup | 33 | 0.23 | 3.5e-06 | -5.8 | 6.1 | 1.2e-09 | -0.91 | 0.00 | 0.99 | FALSE |
21 | The Cancer Genome Atlas | Thyroid Carcinoma | IRF5 | 0.22 | 0.21 | enet | 9 | 0.26 | 4.6e-25 | -5.8 | 6.3 | 3.9e-10 | -0.95 | 0.00 | 1.00 | TRUE |